This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structural features make it valuable in the development of drugs targeting specific receptors or enzymes, particularly in the treatment of central nervous system disorders. The presence of the trifluoromethyl group enhances the compound's metabolic stability and bioavailability, which is crucial for effective drug design. Additionally, it is employed in research settings for the study of biochemical pathways and the development of novel therapeutic agents. Its application extends to the production of chiral compounds, where its stereochemistry plays a critical role in the efficacy of the final drug product.